INDV Stock: Price, Earnings History and SEC Filings
Indivior Pharmaceuticals, Inc. (INDV) last traded at $35.37, up 0.34% on the latest session and down 1.3% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.32 against an analyst estimate of $0.93, a beat of 41.9%.
$35.37 +0.34%
1 month-1.34%
52-week high$42.81
52-week low$27.68
Volume4.61M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
INDV earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $1.32 | $0.93 | +41.94% |
| Jun 2026 | Aug 3, 2026 | $1.15 | $0.97 | +18.56% |
| Mar 2026 | Apr 30, 2026 | $0.96 | $0.64 | +50.00% |
| Dec 2025 | Feb 26, 2026 | $0.82 | $0.65 | +26.15% |
INDV beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for INDV
SEC filing data is not available right now. You can search for INDV on SEC EDGAR.
INDV news
- Indivior Pharmaceuticals (INDV) Could Be 30% Undervalued On Its Turnaround NarrativeOct 30, 2026 · finance.yahoo.com
- Indivior Pharmaceuticals (INDV) Shareholders Back Merger After Record Third QuarterOct 30, 2026 · finance.yahoo.com
- Indivior Pharmaceuticals Inc. (INDV) Beats Q3 Earnings and Revenue EstimatesOct 29, 2026 · finance.yahoo.com
- Indivior Reports Third Quarter 2026 Financial ResultsOct 29, 2026 · finance.yahoo.com
- Updated Effective Date: Huron Consulting Group Set to Join S&P SmallCap 600Oct 28, 2026 · finance.yahoo.com
- MSG Rangers and Huron Consulting Group Set to Join S&P SmallCap 600Oct 22, 2026 · finance.yahoo.com
- Indivior to Report Third Quarter 2026 Financial ResultsOct 19, 2026 · finance.yahoo.com
About Indivior Pharmaceuticals, Inc.
Indivior Pharmaceuticals, Inc. (INDV) is a US-listed public company on Nasdaq.